Potential Impact of Treatment with Inotuzumab Ozogamicin on Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

被引：2

作者：

Ceolin, Valeria ^{[1
,2
]}

Brivio, Erica ^{[2
,3
]}

Rheingold, Susan R. ^{[4
]}

Leahy, Allison Barz ^{[5
]}

Vormoor, Britta Julia ^{[2
]}

O'Brien, Maureen M. ^{[6
]}

Rubinstein, Jeremy ^{[7
]}

Kalwak, Krzysztof ^{[8
]}

De Moerloose, Barbara ^{[9
]}

Jacoby, Elad ^{[10
,11
]}

Bader, Peter ^{[12
]}

Fuster, Jose L. ^{[13
]}

Locatelli, Franco ^{[14
]}

Hoogerbrugge, Peter ^{[2
]}

Calkoen, Friso ^{[2
]}

Zwaan, Christian M. ^{[2
,3
]}

机构：

[1] Univ Turin, Regina Margherita Childrens Hosp, Dept Pediat Oncol Hematol, Turin, Italy

[2] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands

[3] Erasmus Univ, MC Sophia Childrens Hosp, Rotterdam, Netherlands

[4] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Pediat Oncol, Philadelphia, PA USA

[5] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA

[6] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA

[7] Univ Cincinnati, Canc & Blood Dis Inst, Cincinnati Childrens Hosp, Sch Med,Med Ctr, Cincinnati, OH USA

[8] Wroclaw Med Univ, Dept Pediat Hematol Oncol & Bone Marrow Transplan, Wroclaw, Poland

[9] Ghent Univ Hosp, Dept Pediat Oncol Hematol & Stem Cell Transplanta, Ghent, Belgium

[10] Edmond & Lily Safra Childrens Hosp, Div Pediat Hematol Oncol & BMT, Sheba Med Ctr, Tel Aviv, Israel

[11] Sackler Fac Med, Tel Aviv, Israel

[12] Goethe Univ, Univ Hosp Frankfurt, Dept Pediat Oncol Hematol, Clin Children & Youth Med, Frankfurt, Germany

[13] Hosp Valdecilla, Dept Hematol, Pediat Hematol Unit, Santander, Spain

[14] Sapienza Univ Rome, Bambino Gesu Childrens Hosp, Dept Hematol Oncol & Cell & Gene Therapy, Rome, Italy

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-146556

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3824

引用

页码：3824 / +

页数：5

共 50 条

[1] Impact of Treatment with Inotuzumab Ozogamicin before or after Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Lymphoblastic Leukemia
Rheingold, Susan R.
Ji, Lingyun
Gore, Lia
Xu, Xinxin
Bhojwani, Deepa
Shah, Nirali N.
Raetz, Elizabeth A.
Loh, Mignon L.
O'Brien, Maureen M.
[J]. BLOOD, 2023, 142
[2] Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
Valeria Ceolin
Erica Brivio
Harm van Tinteren
Susan R. Rheingold
Allison Leahy
Britta Vormoor
Maureen M. O’Brien
Jeremy D. Rubinstein
Krzysztof Kalwak
Barbara De Moerloose
Elad Jacoby
Peter Bader
Mónica López-Duarte
Bianca F. Goemans
Franco Locatelli
Peter Hoogerbrugge
Friso G. Calkoen
Christian Michel Zwaan
[J]. Leukemia, 2023, 37 : 53 - 60
[3] Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
Ceolin, Valeria
Brivio, Erica
van Tinteren, Harm
Rheingold, Susan R.
Leahy, Allison
Vormoor, Britta
O'Brien, Maureen M.
Rubinstein, Jeremy D.
Kalwak, Krzysztof
De Moerloose, Barbara
Jacoby, Elad
Bader, Peter
Lopez-Duarte, Monica
Goemans, Bianca F.
Locatelli, Franco
Hoogerbrugge, Peter
Calkoen, Friso G.
Zwaan, Christian Michel
[J]. LEUKEMIA, 2023, 37 (01) : 53 - 60
[4] Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia
Uy, Natalie
Nadeau, Michelle
Stahl, Maximilian
Zeidan, Amer M.
[J]. JOURNAL OF BLOOD MEDICINE, 2018, 9 : 67 - 74
[5] Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia
George, Binsah
Kantarjian, Hagop
Jabbour, Elias
Jain, Nitin
[J]. IMMUNOTHERAPY, 2016, 8 (02) : 135 - 143
[6] Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
Oh, Bernice L. Z.
Vinanica, Natasha
Wong, Desmond M. H.
Campana, Dario
[J]. HAEMATOLOGICA, 2024, 109 (06) : 1677 - 1688
[7] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Bhojwani, Deepa
Sposto, Richard
Shah, Nirali N.
Rodriguez, Vilmarie
Yuan, Constance
Stetler-Stevenson, Maryalice
O'Brien, Maureen M.
McNeer, Jennifer L.
Quereshi, Amrana
Cabannes, Aurelie
Schlegel, Paul
Rossig, Claudia
Dalla-Pozza, Luciano
August, Keith
Alexander, Sarah
Bourquin, Jean-Pierre
Zwaan, Michel
Raetz, Elizabeth A.
Loh, Mignon L.
Rheingold, Susan R.
[J]. LEUKEMIA, 2019, 33 (04) : 884 - 892
[8] Cost-effectiveness of chimeric antigen receptor T-cell therapy in pediatric relapsed/refractory acute lymphoblastic leukemia.
Sarkar, Reith
Gloude, Nicholas Joseph
Murphy, James Don
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[9] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani
Richard Sposto
Nirali N. Shah
Vilmarie Rodriguez
Constance Yuan
Maryalice Stetler-Stevenson
Maureen M. O’Brien
Jennifer L. McNeer
Amrana Quereshi
Aurelie Cabannes
Paul Schlegel
Claudia Rossig
Luciano Dalla-Pozza
Keith August
Sarah Alexander
Jean-Pierre Bourquin
Michel Zwaan
Elizabeth A. Raetz
Mignon L. Loh
Susan R. Rheingold
[J]. Leukemia, 2019, 33 : 884 - 892
[10] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia
Lin, John K.
Lerman, Benjamin J.
Barnes, James I.
Boursiquot, Brian C.
Tan, Yuan Jin
Robinson, Alex Q. L.
Davis, Kara L.
Owens, Douglas K.
Goldhaber-Fiebert, Jeremy D.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (32) : 3192 - +

← 1 2 3 4 5 →